Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Ways To Cut Expenses For Better Budgeting outlines practical cuts and smarter choices to free up money for goals.
17,055 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Longbridge Financial and Friday Harbor unveiled a joint AI pre-underwriting platform designed to flag issues early in...
AI infrastructure is booming, but spending fears linger. This piece highlights two credible stock picks that could ri...
A respected advisory firm recently trimmed its stake in Peabody Energy, nudging the stock and sparking questions abou...
When a top toy maker’s stock plunges and an active fund exits, investors sit up and take notice. This article unpacks...
A hedge fund made a sizable Ultragenyx purchase as the stock slipped about 30% over the prior year. This article brea...
Cathie Wood of Ark Invest has sparked big talk about where crypto could go. This article outlines a practical approac...
Plaza Home Mortgage revealed a data breach after unauthorized access to an employee computer, with potential exposure...
Looking for crypto exchanges with the best user experience? This guide breaks down UX essentials, tests to run before...
President Trump taps Bill Pulte to serve as Acting Director of National Intelligence while keeping him at the helm of...
Markets remain choppy as 2026 unfolds. This article lays out practical steps to shield portfolios and stay resilient ...
As AI accelerators push data centers to new speeds, investors who understood the shift decade ago are reaping outsize...